What to Look For in Pfizer’s Earnings
Pfizer is scheduled to release its third-quarter financial results before the markets open on Tuesday.
All Work
Chris Lange
What to Expect From Merck Earnings
Merckis expected to report its third-quarter financial results before the markets open on Tuesday.
How Key Analyst Sees Alphabet After Earnings
Argus maintained a Buy rating on Alphabet but raised its price target after its solid earnings report.
What to Expect From Comcast Earnings
Comcast is scheduled to report its third-quarter financial results before the markets open on Tuesday.
What to Expect From Alibaba Earnings
Alibaba Group is expected to report its fiscal second-quarter financial results before the markets open on Tuesday.
Are Pep Boys Shareholders Getting Enough in the Buyout?
Pep Boys – Manny, Moe & Jack has announced that it has agreed to be acquired by Bridgestone to the tune of $15 per share in an all-cash transaction, totaling $835 million.
Why Merrill Lynch Is Throwing in the Towel on AK Steel and Steel in General
Merrill Lynch was once positive on some of the major players in the steel industry, but now it believes these falling prices could spell disaster for AK Steel or U.S. Steel.
How an FDA Approval Changes the Game for Endo and BioDelivery Sciences
Endo International and BioDelivery Sciences have announced that the U.S. Food and Drug Administration (FDA) approved their long-term opioid treatment, Belbuca.
5 Dow Stocks Reporting Earnings This Week
24/7 Wall St. has put together a preview of Apple, Exxon and some of the major Dow Jones Industrial Average companies that are reporting their quarterly results this week.
8 BioPharma Movers That Cannot Be Ignored
These biotech stocks 24/7 Wall St. has picked stood out from the rest with at least 25% gains over the course of the past week.
Janssen Secures Approval From FDA on New LPS and LMS Drug
ThinkstockJanssen Biotech announced that the U.S. Food and Drug Administration (FDA) approved Yondelis (trabectedin) for the treatment of patients with unresectable or metastatic liposarcoma (LPS) or leiomyosarcoma (LMS) who received a prior anthracycline-containing regimen.…
Centene Receives Overwhelming Approval to Acquire Health Net
ThinkstockFollowing a special shareholder meeting in St. Louis, Centene Corporation (NYSE: CNC) announced that its shareholders voted overwhelmingly to approve the issuance of Centene common stock to shareholders of Health Net, Inc. (NYSE: HNT)…
Why Amgen’s Future Is Looking Bright
Amgen is slowly getting closer to an FDA final decision for its first-of-a-kind cancer therapy, talimogene laherparepvec (T-Vec).
Sirius XM Gears Up for NBA Season
Sirius XM is offering one way for basketball fans to keep up with their favorite teams and players on the go.
PMI Posts Positive Surprise Despite Shrinking Inventories
The latest Markit purchasing managers index (PMI) flash reading surprised economists on Friday.
Why This Analyst Still Thinks Pandora Is a Huge Buy
One key analyst has taken a contrarian position Pandora Media and still sees significant upside from the online music streamer.
Are Proctor & Gamble Earnings Enough for Investors?
Proctor & Gamble reported mixed fiscal first-quarter financial results before the market opened on Friday.
AT&T Rises on Solid Earnings and Guidance
ThinkstockAT&T, Inc. (NYSE: T) reported its third quarter financial results after the markets closed on Thursday. The telecom giant had $0.74 in earnings per share (EPS) on $39.1 billion in revenue compared to Thomson…
Pandora Earnings Fall Flat
ThinkstockPandora Media, Inc. (NYSE: P) reported its third quarter financial results after the markets closed on Thursday. The company had a net loss of $0.40 per share on $311.6 million in revenue compared to…
How FDA Warning Could Spell Disaster for AbbVie and Opportunity for Gilead
ThinkstockThe U.S. Food and Drug Administration (FDA) issued a warning that hepatitis C treatments, Viekira Pak and Technivie, can cause serious liver injury mostly in patients with underlying advanced liver disease. The markets reacted…